Chemotherapy choice in advanced pancreatic cancer: What patient and disease factors influence prescription patterns? Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

abstract

  • 327 Background: FOLFIRINOX (FFX), gemcitabine+nab-paclitaxel (GnP) and gemcitabine monotherapy (Gem)) are universally funded as first-line chemotherapy regimens for advanced pancreatic cancer (APC) in Ontario, Canada. However, there is scarce real-world data on factors that may influence choice of chemotherapy regimens in APC. Methods: Patients who received first-line chemotherapy for APC between April 2015-March 2016 in Ontario were identified from CCO’s New Drug Funding Program database and linked to the Ontario Cancer Registry and other provincial databases to ascertain baseline factors. Multinomial logistic regressions were used to examine the associations between the prescribed chemotherapy regimen and baseline factors. Results: 546 patients were identified, with a mean age of 65 and 43.6% female. 9.9% and 9.7% had received adjuvant gemcitabine and radiation treatment respectively. 17.6% had previous pancreatic resection. 68.3% had zero Charlson score and 30.6% had ECOG performance status (PS) of 0. 72.7% had metastatic disease. The majority of the patients received FFX (52.4%) compared to GnP (35.7%) and Gem (11.9%). Age and ECOG PS were strongly associated with choice of chemotherapy regimens. (See Table) Conclusions: In Ontario, increased patient age and worse ECOG PS are strongly associated with choice of Gem compared to GnP and FFX. Previous treatments and stage of disease also impact chemotherapy choice. Understanding how providers choose chemotherapy in APC aids in comprehending our practices. Odds ratio (OR) and p value from multinomial logistic regressions. [Table: see text]

authors

  • Raskin, William
  • Guo, Helen
  • Beca, Jaclyn Marie
  • Isaranuwatchai, Wanrudee
  • Qiao, Lucy
  • Earle, Craig
  • Berry, Scott R
  • Biagi, James Joseph
  • Welch, Stephen
  • Meyers, Brandon
  • Mittmann, Nicole
  • Coburn, Natalie G
  • Pardhan, Aliya
  • Arias, Jessica
  • Schwartz, Deborah
  • Gavura, Scott
  • Forbes, Leta Marie
  • McLeod, Robin
  • Kennedy, Erin Diane
  • Chan, Kelvin K

publication date

  • February 1, 2018